Stock·NYSE·Consumer Cyclical
RH Inc. (RH)
- Market cap
- $2.57B
- P/E
- 23.98
- Dividend yield
- None
- Street target
- $160.00median of 20 analysts
- 52-week range
- $106.30 $239.40
RH stock forecast today
Where RH stands today, and what CleaRank Financial AI makes of it.
RH at a glance
RH Inc. (RH): Hold, 53/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($132.87 and $154.71).
- Earnings RH beat estimates in 2 of its last 5 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $26.8M and bought $1.8M over the last 18 months.
- Valuation P/E of 24.0 against 20.8 for the Consumer Cyclical sector: broadly in line with peers (+15%).
Figures as of October 26, 2026.
CleaRank Financial AI
RH Inc. (RH) receives a Hold rating from CleaRank, with a model score of 53/100.
The analysts' outlook pushes the score up the most, since the median target is 17.9% above the price. The trend pulls it down the most: the price is 12.27% below its 200-day average and the 50-day average is 14.11% below the 200-day. The 50-day stands at $132.87 and the 200-day at $154.71. Across the past year, the share price declined 25.00%.
Only on CleaRank
Figures we compute ourselves from RH's own price, earnings and insider-filing history. Tap one to see it in context.
RH stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $135.72 is 2.1% above the 50-day simple moving average of $132.87.Price above its 200-day average ›
The price is 12.3% below the 200-day simple moving average of $154.71.50-day average above the 200-day ›
The 50-day average ($132.87) is 14.1% below the 200-day average ($154.71), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 22% of its 52-week range, between $106.30 and $239.40.
RH share price
Pick a period: each tab shows how far RH has moved over it, to the last close.
Today's trading
Where RH sits inside today's range and its 52-week range.
RH fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 23.98 is 15.3% above the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 0.75 is 60.8% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $111.5M on revenue of $3.4B, a net margin of 3.2%.Beat estimates in most recent reports ›
RH beat the EPS estimate in 2 of its last 5 reports.
Key statistics
The headline figures for RH.
As of October 26, 2026, RH trades at $135.72, with a market value of $2.57B and a P/E ratio of 23.98.
What the numbers say
CleaRank Financial AI's reading of RH's valuation, growth and risks.
RH Inc. (RH)'s trailing P/E of 23.98 compares with a Consumer Cyclical median of 20.8, 16.6% above it, which the peer comparison on this page rates as broadly in line with peers. RH trades at 0.75 times its sales, 60.5% below the sector median of 1.9. For scale, RH carries a market capitalisation of $2.6B.
Profitability is the firm's better side. A net margin of 3.23% and an operating margin of 7.18% show how much of each sale reaches profit, and return on equity of 280.72% sits above the sector median of 12.4%. Debt-to-equity of 34.14 completes the balance sheet picture.
RH reported $2.70 per share against an estimate of $0.46 for the September 10, 2026 report, beating it by 486.96%. The stock edged up 0.04% in the following session.
Looking ahead, analysts expect EPS of $5.30 for this fiscal year and $8.48 for the next, so the current year figure implies a decline of 15.7%.
The 30-day standard deviation of RH's daily returns is 3.26%; measured against the S&P 500, its beta is 1.91. The price is 43.31% below its 52-week high of $239.40.
RH against the Consumer Cyclical sector
How RH compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (15% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 14, 2025, RH has lost 37.2% against a gain of 30.2% for SPY.
Performance against SPY
RH and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much RH sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to April 30, 2026); RH reported again on September 10, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 8.1% in FY2026 to $3.4B, from $3.2B a year earlier.
Profit margin: The net margin was 3.6% in FY2026, up from 2.3% the year before.
Profitable: RH earned $125M in FY2026.
Earnings reality check
Did RH beat what analysts expected, and how did the stock react?
Earnings record: RH beat the analyst estimate in 2 of the last 5 quarters.
Market reaction: The stock fell in the first session after 1 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Sep 10, 2026after close | $0.46 | $2.70 | +486.96% | +0.04% | -5.37% |
| Jun 11, 2026after close | -$2.07 | -$1.97 | +4.83% | -3.94% | -7.05% |
| Dec 11, 2025after close | $2.16 | $1.71 | -20.83% | +5.67% | +12.60% |
| Sep 11, 2025after close | $3.22 | $2.93 | -9.01% | -4.60% | +2.34% |
| Apr 2, 2025after close | $1.91 | $1.58 | -17.28% | -40.09% | -22.99% |
As of October 26, 2026, RH has beaten the analyst EPS estimate in 2 of its last 5 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on September 10, 2026, came in 486.96% above the estimate and the stock moved +0.04% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
RH AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/2RSI not overbought or oversold ›
The 14-day RSI is 59.8, in neutral territory.RSI above 50 ›
An RSI of 59.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.
CleaRank Financial AI analysis of RH
The score, the reasoning behind it, and what could move the price next.
RH Inc. (RH) shows a split trend picture. The price of $135.72 is 2.14% above its 50-day average of $132.87, yet it is 12.27% below its 200-day average of $154.71. Near the bottom of its 52-week range, the stock stands 27.68% above the $106.30 low and 43.31% below the $239.40 high. The 50-day average is 14.11% below the 200-day, so the longer average is still pulling the picture down.
Recent gains sit against a weaker longer record: the price rose 9.30% over the past month, fell 24.42% over the past three months and fell 25.00% over the past year. Volume in the last session ran 39.9% below its average, on a day the price fell 1.24%.
Earnings beat ›
The September 10, 2026 report beat the EPS estimate by 486.96%, and the share price rose 0.04% in the first session after it.
Source: Earnings report, September 10, 2026
Rating reaffirmed ›
Goldman Sachs kept its Neutral rating on October 20, 2026.
Source: Analyst action, Goldman Sachs, October 20, 2026
- Two levels matter most right now: the 200-day SMA at $154.71, which sits above the price, and the 50-day SMA at $132.87, which sits below it.
- Readings above 70 or below 30 would signal stretched momentum.
RH is caught between its averages. The price sits above the 50-day average at $132.87 but below the 200-day average at $154.71, so the trend reads as mixed. Reclaiming the 200-day with a close above it would turn both signals up, while a close below the 50-day would turn both down. For now the nearest levels are the 50-day SMA at $132.87 underneath and the 200-day SMA at $154.71 overhead.
Technical indicators
Momentum and trend for RH, from its daily closes.
As of October 26, 2026, with RH at $135.72, its 14-day RSI is 59.8 (neutral territory), its 50-day simple moving average is $132.87 and its 200-day is $154.71.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What RH moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, RH's 1-year correlation of daily returns is +0.52 with S&P 500 (SPY), +0.45 with Nasdaq 100 (QQQ), +0.16 with Bitcoin (BTC) and +0.04 with gold (XAU).
RH price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
7 of 20 analysts rate it a buy or strong buy, 11 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $160.00 is 17.9% above the price.More buy ratings than three months ago ›
7 of 20 rate it a buy now, against 7 of 19 three months ago.
RH Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 20, 2026 | Goldman Sachs | Maintains | Neutral |
| Sep 28, 2026 | Stifel | Maintains | Hold |
| Sep 11, 2026 | Morgan Stanley | Maintains | Overweight |
| Sep 11, 2026 | BNP Paribas | Reiterates | Underperform |
| Sep 11, 2026 | Telsey Advisory Group | Maintains | Market Perform |
| Sep 11, 2026 | JP Morgan | Maintains | Overweight |
As of October 26, 2026, 20 Wall Street analysts cover RH: 7 rate it a buy or strong buy, 11 a hold and 2 a sell or strong sell. Their 12-month price targets range from $81.00 to $258.00. The median RH price target is $160.00, 17.9% above the price of $135.72.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
RH trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
RH trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
RH moves about 3.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much RH tends to move, against the market and on its own.
RH price history and drawdowns
RH's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 3.26% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 85.0%, from August 2021 to October 2026; the price is still 81.6% below that peak.Most 1-year holds ended higher ›
55% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $48,162, against $42,015 in the S&P 500 (SPY).
RH Drawdowns & Recovery
As of October 26, 2026, RH's worst peak-to-trough fall over the last 10 years with dividends reinvested was -85.0% (August 2021 to October 2026); it is still 81.6% below that peak, and 55% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RH in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: RH beat the S&P 500 over this period: $48,162 against $42,015.
A $10,000 investment in RH in October 2016 would be worth about $48,162 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RH, and which have not.
Strongest month, July: an average of +12.80%, up in 8 of 10 years.
Weakest month, February: an average of -4.36%, up in 4 of 10 years.
This month, October: has averaged -3.20%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, RH's strongest calendar month has been July (average +12.80%, up in 8 of 10 years) and its weakest February (average -4.36%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
RH stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RH, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in RH today could grow to about $14,479 by 2030 in the base case, with a 90th-percentile outcome near $52,158 and a 10th-percentile outcome around $4,019. Projections are statistical simulations, not guarantees.
RH Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $197 for RH by 2030 in the base case, from $136 today (1.4x over 4 years). The 10th-percentile path ends near $54.55. These are outcomes of a Monte Carlo simulation run on RH's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $78.44 | $149 | $283 | |
| 2028 | $65.98 | $163 | $404 | |
| 2029 | $59.04 | $179 | $544 | |
| 2030 | $54.55 | $197 | $708 |
Method: a lognormal simulation of RH's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. RH is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
RH insider trading
What the people running the company have bought and sold.
RH insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $1.8M on the open market and sold $26.8M.
As of October 26, 2026, RH insiders reported 9 open-market sales worth $26.8M and 1 open-market purchase worth $1.8M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Mark S Demilio
Director
|
Sell | 2.4K | $411.8K |
| Jul 8, 2026 | Gary G Friedman
Chief Executive Officer
|
Sell | 125.0K | $20.7M |
| Jun 29, 2026 | Carlos E Alberini
Director
|
Buy | 11.4K | $1.8M |
| Jun 18, 2026 | Mark S Demilio
Director
|
Sell | 5.3K | $777.0K |
| Jun 18, 2026 | Carlos E Alberini
Director
|
Grant | 843 | - |
| Jun 18, 2026 | Keith C Belling
Director
|
Grant | 843 | - |
| Jun 18, 2026 | Mark S Demilio
Director
|
Grant | 843 | - |
| Jun 18, 2026 | Hilary K. Krane, J.D.
Director
|
Grant | 843 | - |
| Jun 18, 2026 | Kathleen C Mitic
Director
|
Grant | 843 | - |
| Jun 18, 2026 | Ali Rowghani
Director
|
Grant | 843 | - |
| Jun 18, 2026 | Leonard Arthur Schlesinger
Director
|
Grant | 843 | - |
| Apr 14, 2026 | Mark S Demilio
Director
|
Grant | 13.0K | - |
| Apr 6, 2026 | Eri Chaya
President
|
Option | 25.0K | $985.5K |
| Mar 31, 2026 | Eri Chaya
President
|
Sell | 11.0K | $1.5M |
| Mar 31, 2026 | Eri Chaya
President
|
Option | 11.0K | $433.6K |
| Mar 30, 2026 | Christina Hargarten
Officer
|
Grant | 1.1K | - |
| Mar 24, 2026 | Eri Chaya
President
|
Sell | 7.0K | $906.0K |
| Mar 24, 2026 | Eri Chaya
President
|
Option | 7.0K | $275.9K |
| Mar 17, 2026 | Eri Chaya
President
|
Sell | 7.0K | $947.4K |
| Mar 17, 2026 | Eri Chaya
President
|
Option | 7.0K | $275.9K |
| Jan 30, 2026 | Lisa Chi
Officer
|
Grant | 6.0K | - |
| Jan 14, 2026 | Mark S Demilio
Director
|
Sell | 4.3K | $936.1K |
| Dec 31, 2025 | Mark S Demilio
Director
|
Sell | 900 | $164.1K |
| Sep 19, 2025 | Mark S Demilio
Director
|
Sell | 2.0K | $472.3K |
| Sep 16, 2025 | Mark S Demilio
Director
|
Option | 20.0K | $760.8K |
| Jun 26, 2025 | Carlos E Alberini
Director
|
Grant | 670 | - |
| Jun 26, 2025 | Keith C Belling
Director
|
Grant | 670 | - |
| Jun 26, 2025 | Mark S Demilio
Director
|
Grant | 670 | - |
| Jun 26, 2025 | Hilary K. Krane, J.D.
Director
|
Grant | 670 | - |
| Jun 26, 2025 | Kathleen C Mitic
Director
|
Grant | 670 | - |
| Jun 26, 2025 | Ali Rowghani
Director
|
Grant | 670 | - |
| Jun 26, 2025 | Leonard Arthur Schlesinger
Director
|
Grant | 670 | - |
Source: TwelveData, from SEC Form 4 filings
RH stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.